Cogent Biosciences (NASDAQ:COGT) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Cogent Biosciences (COGT) operate in?

Cogent Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Cogent Biosciences Stock (NASDAQ: COGT) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	159.00 / 1.37M
Day Range	- - -
52 Wk Range	4.28 - 12.61
Market Cap	$784.28M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	26
Short Interest	8.43%
Days to Cover	6

Recent News

Why Is Cogent Biosciences Stock Trading Higher On Monday?

Cogent Biosciences' SUMMIT trial shows bezuclastinib improves symptoms and quality of life in systemic mastocytosis, with favorable safety data.

Vandana Singh

Marinus Pharmaceuticals, Neumora Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session

U.S. stock futures were higher this morning, with the Dow futures gaining over 200 points on Monday.

Avi Kapoor

Why Sony Shares Are Trading Lower By Around 6%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of Sony Group Corporation (NYSE: SONY) fell during Wednesday’s session after the company reported third-quarter financial results and revised guidance above estimates and shared plans to list its financial arm in October 2025.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Sep

Oct

Nov

Dec

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	159.00 / 1.37M
Day Range	- - -
52 Wk Range	4.28 - 12.61
Market Cap	$784.28M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	26
Short Interest	8.43%
Days to Cover	6

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Cogent Biosciences (COGT) stock?

You can purchase shares of Cogent Biosciences (NASDAQ:COGT) through any online brokerage.

View our list of the best stock brokerages

Who are Cogent Biosciences (COGT) competitors?

Other companies in Cogent Biosciences’s space includes: Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Gyre Therapeutics (NASDAQ:GYRE) and Upstream Bio (NASDAQ:UPB).

What is the forecast, or price target, for Cogent Biosciences (COGT) stock?

Cogent Biosciences has a consensus price target of $17.11.

What is the current price for Cogent Biosciences (COGT)?

The stock price for Cogent Biosciences (NASDAQ: COGT) is $7.1 last updated December 20, 2024 at 6:42 AM EST.

Does Cogent Biosciences (COGT) pay a dividend?

There are no upcoming dividends for Cogent Biosciences.

When is Cogent Biosciences (NASDAQ:COGT) reporting earnings?

Cogent Biosciences’s Q4 earnings are confirmed for Monday, February 24, 2025.

Is Cogent Biosciences (COGT) going to split?

There is no upcoming split for Cogent Biosciences.

What sector and industry does Cogent Biosciences (COGT) operate in?

Cogent Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Cogent Biosciences

Cogent Biosciences (COGT) Forecast